RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX

Clinical trials for RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX explained in plain language.

Never miss a new study

Get alerted when new RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX trials appear

Sign up with your email to follow new studies for RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test drug duo in battle against tough head and neck cancers

Disease control Completed

This study tested whether combining two cancer drugs, cetuximab and sorafenib, works better than using cetuximab alone for people with advanced head and neck cancer that has returned or spread. Fifty-five participants were randomly assigned to receive either the combination or th…

Matched conditions: RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX

Get alerted when new RECURRENT SQUAMOUS CELL CARCINOMA OF THE NASOPHARYNX trials appear

Scientists test drug duo in battle against tough head and neck cancers